XML 91 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements Of Cash Flows (USD $)
12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
CASH FLOWS FROM OPERATING ACTIVITIES      
Net income $ 113,709,000 $ 121,613,000 $ 111,061,000
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 9,582,000 8,226,000 8,024,000
Provision for bad debts, net 2,743,000 2,923,000 2,192,000
Non-cash stock compensation and other charges 11,271,000 12,375,000 14,511,000
Non-cash interest and other (income) loss 1,545,000 292,000 2,208,000
Loss on extinguishment of debt 0 526,000 0
Dividends received from equity method investments 1,445,000 1,310,000 1,139,000
Deferred income taxes (6,277,000) (1,126,000) 5,866,000
Equity in net income of affiliates (634,000) (212,000) (269,000)
Changes in assets and liabilities:      
Receivables (7,899,000) (6,807,000) (9,764,000)
Advances to/from marketing and reservation activities, net 42,991,000 30,983,000 1,553,000
Forgivable notes receivable, net (8,347,000) (10,898,000) (3,475,000)
Accounts payable 2,304,000 11,000 (1,851,000)
Accrued expenses (9,595,000) 12,376,000 6,346,000
Income taxes payable/receivable 4,276,000 (2,662,000) (4,562,000)
Deferred revenue (9,861,000) 2,188,000 1,523,000
Other assets (3,197,000) (3,476,000) (3,162,000)
Other liabilities 9,857,000 (17,520,000) 29,000
Net cash provided by operating activities 153,913,000 150,122,000 131,369,000
CASH FLOWS FROM INVESTING ACTIVITIES      
Investment in property and equipment (33,397,000) (15,443,000) (10,924,000)
Equity method investments (5,685,000) (20,285,000) (5,000,000)
Issuance of mezzanine and other notes receivable (1,095,000) (23,736,000) (9,227,000)
Collections of mezzanine and other notes receivable 9,748,000 3,270,000 4,690,000
Purchases of investments, employee benefit plans (2,676,000) (1,697,000) (1,602,000)
Proceeds from sales of investments, employee benefit plans 4,168,000 11,223,000 644,000
Proceeds from sale of assets 243,000 0 1,654,000
Other items, net (728,000) (433,000) (564,000)
Net cash used in investing activities (29,422,000) (47,101,000) (20,329,000)
CASH FLOWS FROM FINANCING ACTIVITIES      
Proceeds from the issuance of long-term debt 3,360,000 543,500,000 75,000
Net borrowings (repayments) pursuant to revolving credit facilities (57,000,000) 57,000,000 (200,000)
Principal payments on long-term debt (8,204,000) (4,422,000) (297,000)
Debt issuance costs 0 (4,759,000) (2,356,000)
Excess tax benefits from stock-based compensation 1,460,000 1,559,000 1,227,000
Purchase of treasury stock (3,965,000) (22,586,000) (53,617,000)
Dividends paid (32,799,000) (654,092,000) (43,747,000)
Proceeds from exercise of stock options 8,864,000 7,090,000 3,845,000
Net cash used in financing activities (88,284,000) (76,710,000) (95,070,000)
Net change in cash and cash equivalents 36,207,000 26,311,000 15,970,000
Effect of foreign exchange rate changes on cash and cash equivalents (2,589,000) 809,000 (172,000)
Cash and cash equivalents at beginning of period 134,177,000 107,057,000 91,259,000
Cash and cash equivalents at end of period 167,795,000 134,177,000 107,057,000
Cash payments during the year for:      
Income taxes, net of refunds 47,513,000 51,548,000 45,483,000
Interest 43,327,000 16,954,000 15,527,000
Non-cash investing and financing activities:      
Dividends declared but not paid 10,785,000 1,000 10,719,000
Equity method investments 0 3,900,000 0
Capital lease obligation 0 0 908,000
Debt issuance costs 0 6,500,000 0
Issuance of treasury stock to employee stock purchase plan 0 0 739,000
Investment in property and equipment acquired in accounts payable 658,000 0 0
Restricted Stock [Member]
     
Non-cash investing and financing activities:      
Issuance of restricted shares of common stock and performance vested restricted stock units 8,500,000 9,517,000 9,604,000
Performance Vested Restricted Stock Units [Member]
     
CASH FLOWS FROM FINANCING ACTIVITIES      
Dividends paid (500,000) 0  
Non-cash investing and financing activities:      
Issuance of restricted shares of common stock and performance vested restricted stock units $ 1,298,000 $ 0 $ 0